Funder: Pershing Square Philanthropies
Due Dates (Anticipated): November 2026 (Letter of Intent)
Funding Amounts: $750,000 total ($250,000/year for 3 years); minimum of 6 awards annually
Summary: Supports early-career scientists in the USA with substantial funding and networking to advance innovative, high-risk cancer research.
Key Information: As of 2026, open to all US institutions; only LOI required (no full proposal stage).